Balance Sheet

Cash Flow Statement

Acquisitions Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Orthopediatrics (KIDS) Cash from Discontinued Operations (2019)

Orthopediatrics has reported Cash from Discontinued Operations over the past 1 years, most recently at 734000.0 for Q4 2019.

For Q4 2019, Cash from Discontinued Operations changed N/A year-over-year to 734000.0; the TTM value through Dec 2020 reached 515000.0, changed 0.0%, while the annual FY2019 figure was 144000.0, N/A changed from the prior year.
Cash from Discontinued Operations for Q4 2019 was 734000.0 at Orthopediatrics, down from 219000.0 in the prior quarter.
Over five years, Cash from Discontinued Operations peaked at 219000.0 in Q3 2019 and troughed at 734000.0 in Q4 2019.